Emergent Biosolutions Inc
EBS - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$304.7M
Close$
$-7.39
225.1% downside
Current Fair Value
225.1% downsideOvervalued by 225.1% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $304.70 Million |
|---|---|
| Enterprise Value | $761.80 Million |
| Earnings per Share | $0.98 |
| Beta | 2.29 |
| Outstanding Shares | 51,600,000 |
Return
| Return on Equity | -53.78% |
|---|---|
| Return on Assets | -16.44% |
| Return on Invested Capital | -3.05% |
Valuation & Multiples
| P/E Ratio | -1.98 |
|---|---|
| PEG | -0.14 |
| Price to Sales | 0.42 |
| Price to Book Ratio | 0.98 |
| Enterprise Value to Revenue | 0.99 |
| Enterprise Value to EBIT | -25.14 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0.78 |
| Debt to Equity | 1.75 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 4, 2026
EPS Estimate
$-0.37
Consensus analyst estimateRevenue Estimate
$123.22 M
Consensus analyst estimateNext Earnings Call
Expected Date
February 25, 2027
EPS Estimate
$-0.16
Consensus analyst estimateRevenue Estimate
$137.50 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.0000▼ 33.77% |
|---|---|
| Total Calls | 400▼ 99.91% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 4.07%▼ 84.67% |
|---|---|
| Total Invested | $13.87M▼ 96.39% |
| Investors Holding | 41▼ 160.00% |
About Emergent Biosolutions Inc
900 employees
CEO: Robert Kramer
Emergent BioSolutions Inc. is a life sciences enterprise dedicated to developing and delivering solutions for preparing for and responding to diverse public health threats (PHTs) in the United States. Its mission involves countering unfo...